Results of the meta-analysis demonstrated that thymosin adjuvant chemotherapy increased objective remission and overall response rates and CD4+ and NK cells and decreased thrombocytopenia and CD4+/CD8+ ratio compared to chemotherapy alone [21]. Here, CD4 is linked to Thrombocytopenia.